Advertisement

Molecular Neurobiology

, Volume 54, Issue 9, pp 7171–7185 | Cite as

Promotion of the Unfolding Protein Response in Orexin/Dynorphin Neurons in Sudden Infant Death Syndrome (SIDS): Elevated pPERK and ATF4 Expression

  • Nicholas J. Hunt
  • Karen A. Waters
  • Rita MachaalaniEmail author
Article

Abstract

We previously demonstrated that sudden infant death syndrome (SIDS) infants have decreased orexin immunoreactivity within the hypothalamus and pons compared to non-SIDS infants. In this study, we examined multiple mechanisms that may promote loss of orexin expression including programmed cell death, impaired maturation/structural stability, neuroinflammation and impaired unfolding protein response (UPR). Immunofluorescent and immunohistochemical staining for a number of markers was performed in the tuberal hypothalamus and pons of infants (1–10 months) who died from SIDS (n = 27) compared to age- and sex-matched non-SIDS infants (n = 19). The markers included orexin A (OxA), dynorphin (Dyn), cleaved caspase 3 (CC3), cleaved caspase 9 (CC9), glial fibrillary acid protein (GFAP), tubulin beta chain 3 (TUBB3), myelin basic protein (MBP), interleukin 1β (IL-1β), terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL), c-fos and the UPR activation markers: phosphorylated protein kinase RNA-like endoplasmic reticulum kinase (pPERK), and activating transcription factor 4 (ATF4). It was hypothesised that pPERK and ATF4 would be upregulated in Ox neurons in SIDS compared to non-SIDS. Within the hypothalamus, OxA and Dyn co-localised with a 20 % decrease in expression in SIDS infants (P = 0.001). pPERK and ATF4 expression in OxA neurons were increased by 35 % (P = 0.001) and 15 % (P = 0.001) respectively, with linear relationships between the decreased OxA/Dyn expression and the percentages of co-localised pPERK/OxA and ATF4/OxA evident (P = 0.01, P = 0.01). No differences in co-localisation with CC9, CC3, TUNEL or c-fos, nor expression of MBP, TUBB3, IL-1β and GFAP, were observed in the hypothalamus. In the pons, there were 40 % and 20 % increases in pPERK expression in the locus coeruleus (P = 0.001) and dorsal raphe (P = 0.022) respectively; ATF4 expression was not changed. The findings that decreased orexin levels in SIDS infants may be associated with an accumulation of pPERK suggest decreased orexin translation. As pPERK may inhibit multiple neuronal groups in the pons in SIDS infants, it could also indicate that a common pathway promotes loss of protein expression and impaired functionality of multiple brainstem neuronal groups.

Keywords

UPR ATF4 CREB Development Sleep Hypocretin 

Abbreviations

3V

Third ventricle

ATF4

Activating transcription factor 4

BiP

Binding immunogen protein

CC3

Cleaved caspase 3

CC9

Cleaved caspase 9

CHOP

CCAAT-enhancer-binding protein homologous protein

dH2O

Deionised water

DMH

Dorsal medial hypothalamus

DR

Dorsal raphe

Dyn

Dynorphin

ER

Endoplasmic reticulum

GFAP

Glial fibrillary acid protein

IF

Immunofluorescence

IHC

Immunohistochemistry

IL-1β

Interleukin 1-beta

LC

Locus coeruleus

LH

Lateral hypothalamus

Lipo

Lipofuscin

MBP

Myelin basic protein

NHS

Normal horse serum

Ox

Orexin

OxA

Orexin A

PBS

Phosphate-buffered saline

PeF

Perifornical area

pPERK

Phosphorylated protein kinase RNA-like endoplasmic reticulum kinase

PPO

Prepro-orexin

REM

Rapid eye movement

SIDS

Sudden infant death syndrome

THT

Tuberal hypothalamus

TUBB3

Tubulin beta chain 3

TUNEL

Terminal deoxynucleotidyl transferase dUTP nick-end labelling

UPR

Unfolding protein response

URTIs

Upper respiratory tract infections

Notes

Acknowledgments

The tissue used in this study was obtained from the NSW Forensic and Analytical Science Service. The authors acknowledge the facilities and scientific and technical assistance of the Australian Microscopy and Microanalysis Research Faculty at the Australian Centre of Microscopy and Micro Analysis, University of Sydney.

Compliance with Ethical Standards

Funding

This research was funded by the SIDS Stampede, Australia, and the Miranda Belshaw Foundation.

Conflict of Interest

The authors declare that they have no conflicts of interest.

Supplementary material

12035_2016_234_MOESM1_ESM.docx (27 kb)
Supplementary Table 1 (DOCX 27 kb)
12035_2016_234_MOESM2_ESM.docx (33 kb)
Supplementary Table 2 (DOCX 33 kb)
12035_2016_234_Fig7_ESM.gif (447 kb)
Supplementary Figure 1

Changes in OxA, Dyn, CC3 and TUNEL (TUN) in the nuclei and regions of the tuberal hypothalamus (THT). No changes in CC3 or TUN were observed in any nuclei or levels of the THT between non-SIDS and SIDS cases. Decreased expression was observed overall in the anterior THT (OxA: F 1,7 = 6.75, P = 0.036; Dyn: F 1,7 = 6.75, P = 0.036), and within the PeF, LH and overall of the central THT (OxA: F 1,23 = 9.78, 10.79, 14.16; P = 0.005, 0.003, 0.001; Dyn: F 1,23 = 10.54, 6.23, 12.44; P = 0.004, 0.02, 0.001) and posterior THT (OxA: F 1,10 = 6.44, 12.94, 21.00; P = 0.034, 0.005, 0.001; Dyn: F 1,10 = 5.82, 9.64, 23.00; P = 0.044, 0.011, 0.001). (GIF 446 kb)

12035_2016_234_MOESM3_ESM.tif (12.1 mb)
High resolution image (TIFF 12385 kb)
12035_2016_234_Fig8_ESM.gif (121 kb)
Supplementary Figure 2

No differences in Ox neuron size (a–c) or total THT neuronal numbers (d–f) between non-SIDS and SIDS infants within the anterior, central or posterior THT. (GIF 120 kb)

12035_2016_234_MOESM4_ESM.tif (9.8 mb)
High resolution image (TIFF 10053 kb)
12035_2016_234_Fig9_ESM.gif (73 kb)
Supplementary Figure 3

Co-localisation of c-fos and OxA was not different between non-SIDS and SIDS infants. (a) non-SIDS and (b) SIDS expression staining images, OxA staining was observed in the cytoplasm of neurons and c-fos expression in the nucleus. (c) box and whisker plot comparing non-SIDS and SIDS co-localised c-fos/OxA expression. (GIF 73 kb)

12035_2016_234_MOESM5_ESM.tif (6.5 mb)
High resolution image (TIFF 6692 kb)
12035_2016_234_Fig10_ESM.gif (158 kb)
Supplementary Figure 4

(GIF 158 kb)

12035_2016_234_MOESM6_ESM.tif (5.3 mb)
High resolution image (TIFF 5395 kb)

References

  1. 1.
    Krous H (2010) Sudden unexpected death in infancy and the dilemma of defining the sudden infant death syndrome. Curr Pediatr Rev 6(1):5–12CrossRefGoogle Scholar
  2. 2.
    Cornwell AC, Feigenbaum P (2006) Sleep biological rhythms in normal infants and those at high risk for SIDS. Chronobiol Int 23(5):935–961CrossRefPubMedGoogle Scholar
  3. 3.
    Kato I, Franco P, Groswasser J, Scaillet S, Kelmanson I, Togari H, Kahn A (2003) Incomplete arousal processes in infants who were victims of sudden death. Am J Respir Crit Care Med 168(11):1298–1303CrossRefPubMedGoogle Scholar
  4. 4.
    Schechtman VL, Harper RM, Kluge KA, Wilson AJ, Hoffman HJ, Southall DP (1989) Heart rate variation in normal infants and victims of the sudden infant death syndrome. Early Hum Dev 19(3):167–181CrossRefPubMedGoogle Scholar
  5. 5.
    Kahn A, Groswasser J, Rebuffat E, Sottiaux M, Blum D, Foerster M, Franco P, Bochner A et al (1992) Sleep and cardiorespiratory characteristics of infant victims of sudden death: a prospective case-control study. Sleep 15(4):287–292CrossRefPubMedGoogle Scholar
  6. 6.
    Thach BT (2015) Potential central nervous system involvement in sudden unexpected infant deaths and the sudden infant death syndrome. Compr Physiol 5(3):1361–1368Google Scholar
  7. 7.
    Machaalani R, Waters KA (2014) Neurochemical abnormalities in the brainstem of the sudden infant death syndrome (SIDS). Paediatr Respir Rev 15(4):293–300PubMedGoogle Scholar
  8. 8.
    Hunt NJ, Waters KA, Rodriguez ML, Machaalani R (2015) Decreased orexin (hypocretin) immunoreactivity in the hypothalamus and pontine nuclei in sudden infant death syndrome. Acta Neuropathol 130(2):185–198CrossRefPubMedGoogle Scholar
  9. 9.
    Crocker A, España RA, Papadopoulou M, Saper CB, Faraco J, Sakurai T, Honda M, Mignot E et al (2005) Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65(8):1184–1188CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Blouin A, Thannickal T, Worley P, Baraban J, Reti I, Siegel J (2005) Narp immunostaining of human hypocretin (orexin) neurons loss in narcolepsy. Neurology 65(8):1189–1192CrossRefPubMedGoogle Scholar
  11. 11.
    Gestreau C, Bévengut M, Dutschmann M (2008) The dual role of the orexin/hypocretin system in modulating wakefulness and respiratory drive. Curr Opin Pulm Med 14(6):512–518CrossRefPubMedGoogle Scholar
  12. 12.
    Sakurai T, Mieda M (2011) Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Phamacol Sci 32(8):451–462CrossRefGoogle Scholar
  13. 13.
    Plaza-Zabala A, Maldonado R, Berrendero F (2012) The hypocretin/orexin system: implications for drug reward and relapse. Mol Neurobiol 45(3):424–439CrossRefPubMedGoogle Scholar
  14. 14.
    Hunt NJ, Russell B, Du MK, Waters KA, Machaalani R (2016) Changes in orexinergic immunoreactivity of the piglet hypothalamus and pons after exposure to chronic postnatal nicotine and intermittent hypercapnic hypoxia. Eur J Neurosci 43(12):1612–1622CrossRefPubMedGoogle Scholar
  15. 15.
    Hunt NJ, Rodriguez ML, Waters KA, Machaalani R (2015) Changes in orexin (hypocretin) neuronal expression with normal aging in the human hypothalamus. Neurobiol Aging 36(1):292–300CrossRefPubMedGoogle Scholar
  16. 16.
    Blumberg MS, Coleman CM, Johnson ED, Shaw C (2007) Developmental divergence of sleep-wake patterns in orexin knockout and wild-type mice. Eur J Neurosci 25(2):512–518CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Michinaga S, Hisatsune A, Isohama Y, Katsuki H (2011) Orexin neurons in hypothalamic slice cultures are vulnerable to endoplasmic reticulum stress. J Neurosci 190:289–300CrossRefGoogle Scholar
  18. 18.
    Obukuro K, Nobunaga M, Takigawa M, Morioka H, Hisatsune A, Isohama Y, Shimokawa H, Tsutsui M et al (2013) Nitric oxide mediates selective degeneration of hypothalamic orexin neurons through dysfunction of protein disulfide isomerase. J Neurosci 33(31):12557–12568CrossRefPubMedGoogle Scholar
  19. 19.
    Obukuro K, Takigawa M, Hisatsune A, Isohama Y, Katsuki H (2010) Quinolinate induces selective loss of melanin-concentrating hormone neurons, rather than orexin neurons, in the hypothalamus of mice and young rats. J Neurosci 170(1):298–307CrossRefGoogle Scholar
  20. 20.
    Hunt NJ, Phillips L, Waters KA, Machaalani R (2016) Proteomic MALDI-TOF/TOF-IMS examination of peptide expression in the formalin fixed brainstem and changes in sudden infant death syndrome infants. J Proteome 138:48–60CrossRefGoogle Scholar
  21. 21.
    Basu A, Krady JK, Levison SW (2004) Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res 78(2):151–156CrossRefPubMedGoogle Scholar
  22. 22.
    Perekrest SV, Abramova TV, Novikova NS, Loskutov YV, Rogers VJ, Korneva EA (2008) Changes in immunoreactivity of orexin-A-positive neurons after intravenous lipopolysaccharide injection. Med Sci Monit 14(7):BR127–BR133PubMedGoogle Scholar
  23. 23.
    Zhu Y, Fenik P, Zhan G, Xin R, Veasey SC (2015) Degeneration in arousal neurons in chronic sleep disruption modeling sleep apnea. Front Neurol 6:109CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495–516CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Du MK, Hunt NJ, Waters KA, Machaalani R (2016) Cumulative effects of repetitive intermittent hypercapnic hypoxia on orexin in the developing piglet hypothalamus. Int J Dev Neurosci 48:1–8CrossRefPubMedGoogle Scholar
  26. 26.
    Landry JP, Hawkins C, Wiebe S, Balaban E, Pompeiano M (2014) Opposing effects of hypoxia on catecholaminergic locus coeruleus and hypocretin/orexin neurons in chick embryos. Dev Neurobiol 74(10):1030–1037CrossRefPubMedGoogle Scholar
  27. 27.
    Hundahl CA, Luuk H, Ilmjärv S, Falktoft B, Raida Z, Vikesaa J, Friis-Hansen L, Hay-Schmidt A (2011) Neuroglobin-deficiency exacerbates Hif1A and c-FOS response, but does not affect neuronal survival during severe hypoxia in vivo. PLoS One 6(12):e28160CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Yamaguchi K, Futatsuki T, Ushikai J, Kuroki C, Minami T, Kakihana Y, Kuwaki T (2015) Intermittent but not sustained hypoxia activates orexin-containing neurons in mice. Respir Physiol Neurobiol 206:11–14CrossRefPubMedGoogle Scholar
  29. 29.
    Zhu Y, Fenik P, Zhan G, Mazza E, Kelz M, Aston-Jones G, Veasey SC (2007) Selective loss of catecholaminergic wake–active neurons in a murine sleep apnea model. J Neurosci 27(37):10060–10071CrossRefPubMedGoogle Scholar
  30. 30.
    Naidoo N, Zhu J, Zhu Y, Fenik P, Lian J, Galante R, Veasey S (2011) Endoplasmic reticulum stress in wake-active neurons progresses with aging. Aging Cell 10(4):640–649CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Koumenis C, Naczki C, Koritzinsky M, Rastani S, Diehl A, Sonenberg N, Koromilas A, Wouters BG (2002) Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2α. Mol Biol Cell 22(21):7405–7416CrossRefGoogle Scholar
  32. 32.
    Kumar R, Azam S, Sullivan JM, Owen C, Cavener DR, Zhang P, Ron D, Harding HP et al (2001) Brain ischemia and reperfusion activates the eukaryotic initiation factor 2α kinase, PERK. J Neurochem 77(5):1418–1421CrossRefPubMedGoogle Scholar
  33. 33.
    DeGracia DJ, Montie HL (2004) Cerebral ischemia and the unfolded protein response. J Neurochem 91(1):1–8CrossRefPubMedGoogle Scholar
  34. 34.
    Paxinos G, Huang X-F (1995) Atlas of the human brainstem, 1st Edition. Achedemic Press, San DiegoGoogle Scholar
  35. 35.
    Mai JK, Paxinos G, Voss T (2008) Atlas of the human brain. Academic Press, Inc, San DiegoGoogle Scholar
  36. 36.
    Kaur S, Thankachan S, Begum S, Blanco-Centurion C, Sakurai T, Yanagisawa M, Shiromani PJ (2008) Entrainment of temperature and activity rhythms to restricted feeding in orexin knock out mice. Brain Res 1205:47–54CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Oppenheim RW, Flavell RA, Vinsant S, Prevette D, Kuan C-Y, Rakic P (2001) Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J Neurosci 21(13):4752–4760PubMedGoogle Scholar
  38. 38.
    Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, Hu N, Harding H, Novoa I et al (2005) ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J 24(19):3470–3481CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Horton JK, Siamakpour-Reihani S, Lee C-T, Zhou Y, Chen W, Geradts J, Fels DR, Hoang P et al (2015) FAS death receptor: a breast cancer subtype-specific radiation response biomarker and potential therapeutic target. Radiat Res 184(5):456–469CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Chaturvedi V, Bodner B, Qin J-Z, Nickoloff BJ (2006) Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway. J Dermatol Sci 41(1):31–41CrossRefPubMedGoogle Scholar
  41. 41.
    Li W, Zhai B, Zhi H, Li Y, Jia L, Ding C, Zhang B, You W (2014) Association of ABCB1, β tubulin I, and III with multidrug resistance of MCF7/DOC subline from breast cancer cell line MCF7. Tumor Biol 35(9):8883–8891CrossRefGoogle Scholar
  42. 42.
    Hsu K-W, Hsieh R-H, Wu C-W, Chi C-W, Lee Y-HW, Kuo M-L, Wu K-J, Yeh T-S (2009) MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2. Mol Biol Cell 20(24):5127–5137CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Chou TC, Lee CE, Lu J, Elmquist JK, Hara J, Willie JT, Beuckmann CT, Chemelli RM et al (2001) Orexin (hypocretin) neurons contain dynorphin. J Neurosci 21(19):1–6Google Scholar
  44. 44.
    Hou X, Liu Y, Liu H, Chen X, Liu M, Che H, Guo F, Wang C et al (2015) PERK silence inhibits glioma cell growth under low glucose stress by blockage of p-AKT and subsequent HK2's mitochondria translocation. Sci Rep 5(9065). doi: 10.1038/srep09065
  45. 45.
    Moeton M, Kanski R, Stassen OM, Sluijs JA, Geerts D, van Tijn P, Wiche G, van Strien ME et al (2014) Silencing GFAP isoforms in astrocytoma cells disturbs laminin-dependent motility and cell adhesion. FASEB 28(7):2942–2954CrossRefGoogle Scholar
  46. 46.
    Santangelo KS, Nuovo GJ, Bertone AL (2012) In vivo reduction or blockade of interleukin-1β in primary osteoarthritis influences expression of mediators implicated in pathogenesis. Osteoarthr Cartilage 20(12):1610–1618. doi: 10.1016/j.joca.2012.08.011 CrossRefGoogle Scholar
  47. 47.
    Machaalani R, Waters KA (2008) Neuronal cell death in the sudden infant death syndrome brainstem and associations with risk factors. Brain 131(1):218–228CrossRefPubMedGoogle Scholar
  48. 48.
    Stern AL, Naidoo N (2015) Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease. SpringerPlus 4(1):25. doi: 10.1186/s40064-014-0777-6 CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Hoozemans J, Van Haastert E, Eikelenboom P, De Vos R, Rozemuller J, Scheper W (2007) Activation of the unfolded protein response in Parkinson’s disease. Biochem Biophys Res Commun 354(3):707–711CrossRefPubMedGoogle Scholar
  50. 50.
    Hoozemans J, Veerhuis R, Van Haastert E, Rozemuller J, Baas F, Eikelenboom P, Scheper W (2005) The unfolded protein response is activated in Alzheimer’s disease. Acta Neuropathol 110(2):165–172CrossRefPubMedGoogle Scholar
  51. 51.
    Smith HL, Mallucci GR (2016) The unfolded protein response: mechanisms and therapy of neurodegeneration. Brain. doi: 10.1093/brain/aww101 Google Scholar
  52. 52.
    Wu J, Kaufman R (2006) From acute ER stress to physiological roles of the unfolded protein response. Cell Death Differ 13(3):374–384CrossRefPubMedGoogle Scholar
  53. 53.
    Broadbelt KG, Rivera KD, Paterson DS, Duncan JR, Trachtenberg FL, Paulo JA, Stapels MD, Borenstein NS et al (2012) Brainstem deficiency of the 14-3-3 regulator of serotonin synthesis: a proteomics analysis in the sudden infant death syndrome. Mol Cell Proteomics 11(1):M111. 009530CrossRefPubMedGoogle Scholar
  54. 54.
    Bodalia A, Li H, Jackson MF (2013) Loss of endoplasmic reticulum Ca2+ homeostasis: contribution to neuronal cell death during cerebral ischemia. Acta Pharmacol Sin 34(1):49–59CrossRefPubMedGoogle Scholar
  55. 55.
    Wong MK, Nicholson CJ, Holloway AC, Hardy DB (2015) Maternal nicotine exposure leads to impaired disulfide bond formation and augmented endoplasmic reticulum stress in the rat placenta. PLoS One 10(3):e0122295. doi: 10.1371/journal.pone.0122295 CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    De Felice FG, Lourenco MV (2015) Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease. Front Aging Neurosci 7:94. doi: 10.3389/fnagi.2015.00094 CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Hettiarachchi KD, Zimmet PZ, Myers MA (2008) Dietary toxins, endoplasmic reticulum (ER) stress and diabetes. Curr Diabetes Rev 4(2):146–156CrossRefPubMedGoogle Scholar
  58. 58.
    Qian Y, Tiffany-Castiglioni E (2003) Lead-induced endoplasmic reticulum (ER) stress responses in the nervous system. Neurochem Res 28(1):153–162CrossRefPubMedGoogle Scholar
  59. 59.
    Pavlovsky AA, Boehning D, Li D, Zhang Y, Fan X, Green TA (2013) Psychological stress, cocaine and natural reward each induce endoplasmic reticulum stress genes in rat brain. J Neurosci 246:160–169CrossRefGoogle Scholar
  60. 60.
    Wang H, Wang X, Ke Z-J, Comer AL, Xu M, Frank JA, Zhang Z, Shi X et al (2015) Tunicamycin-induced unfolded protein response in the developing mouse brain. Toxicol Appl Pharmacol 283(3):157–167CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Chakrabarti A, Chen AW, Varner JD (2011) A review of the mammalian unfolded protein response. Biotechnol Bioeng 108(12):2777–2793CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Brown MK, Naidoo N (2010) The UPR and the anti-oxidant response: relevance to sleep and sleep loss. Mol Neurobiol 42(2):103–113CrossRefPubMedGoogle Scholar
  63. 63.
    Malhotra JD, Kaufman RJ (2007) The endoplasmic reticulum and the unfolded protein response. In: Sem Cell Dev Biol, vol 6. Elsevier, pp 716–731Google Scholar
  64. 64.
    Rutkowski DT, Kaufman RJ (2004) A trip to the ER: coping with stress. Trends Cell Biol 14(1):20–28CrossRefPubMedGoogle Scholar
  65. 65.
    Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, Ron D (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6(5):1099–1108CrossRefPubMedGoogle Scholar
  66. 66.
    Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D (2000) Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 5(5):897–904CrossRefPubMedGoogle Scholar
  67. 67.
    Harding HP, Zhang Y, Ron D (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397(6716):271–274CrossRefPubMedGoogle Scholar
  68. 68.
    Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C et al (2003) An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11(3):619–633CrossRefPubMedGoogle Scholar
  69. 69.
    Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334(6059):1081–1086CrossRefPubMedGoogle Scholar
  70. 70.
    Machaalani R, Rodriguez M, Waters K (2007) Active caspase-3 in the sudden infant death syndrome (SIDS) brainstem. Acta Neuropathol 113(5):577–584CrossRefPubMedGoogle Scholar
  71. 71.
    Kadhim H, Kahn A, Sébire G (2003) Distinct cytokine profile in SIDS brain a common denominator in a multifactorial syndrome? Neurology 61(9):1256–1259CrossRefPubMedGoogle Scholar
  72. 72.
    Santhanasabapathy R, Sudhandiran G (2015) Farnesol attenuates lipopolysaccharide-induced neurodegeneration in Swiss albino mice by regulating intrinsic apoptotic cascade. Brain Res 1620:42–56CrossRefPubMedGoogle Scholar
  73. 73.
    Duncan JR, Paterson DS, Hoffman JM, Mokler DJ, Borenstein NS, Belliveau RA, Krous HF, Haas EA et al (2010) Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA 303(5):430–437CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Lavezzi AM, Ottaviani G, Mingrone R, Matturri L (2005) Analysis of the human locus coeruleus in perinatal and infant sudden unexplained deaths. Possible role of the cigarette smoking in the development of this nucleus. Dev Brain Res 154(1):71–80CrossRefGoogle Scholar
  75. 75.
    Chen L, Thakkar MM, Winston S, Bolortuya Y, Basheer R, McCarley RW (2006) REM sleep changes in rats induced by siRNA-mediated orexin knockdown. Eur J Neurosci 24(7):2039–2048CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Cornwell AC, Feigenbaum P, Kim A (1998) SIDS, abnormal nighttime REM sleep and CNS immaturity. Neuropediatr 29(02):72–79CrossRefGoogle Scholar
  77. 77.
    Li A, Nattie E (2008) Serotonin transporter knockout mice have a reduced ventilatory response to hypercapnia (predominantly in males) but not to hypoxia. J Physiol 586(9):2321–2329CrossRefPubMedPubMedCentralGoogle Scholar
  78. 78.
    Wisor J, Wurts S, Hall F, Lesch K, Murphy D, Uhl G, Edgar D (2003) Altered rapid eye movement sleep timing in serotonin transporter knockout mice. Neuroreport 14(2):233–238CrossRefPubMedGoogle Scholar
  79. 79.
    Hodges MR, Richerson GB (2010) The role of medullary serotonin (5-HT) neurons in respiratory control: contributions to eupneic ventilation, CO2 chemoreception, and thermoregulation. J Appl Physiol 108(5):1425–1432CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Hodges MR, Richerson GB (2010) Medullary serotonin neurons and their roles in central respiratory chemoreception. Respir Physiol Neurobiol 173(3):256–263CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Hilaire G, Voituron N, Menuet C, Ichiyama RM, Subramanian HH, Dutschmann M (2010) The role of serotonin in respiratory function and dysfunction. Respir Physiol Neurobiol 174(1):76–88CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Kantor S, Mochizuki T, Janisiewicz AM, Clark E, Nishino S, Scammell TE (2009) Orexin neurons are necessary for the circadian control of REM sleep. Sleep 32(9):1127–1134CrossRefPubMedPubMedCentralGoogle Scholar
  83. 83.
    Williams KS, Behn CGD (2011) Dynamic interactions between orexin and dynorphin may delay onset of functional orexin effects: a modeling study. J Biol Rhythm 26(2):171–181CrossRefGoogle Scholar
  84. 84.
    Winsky-Sommerer R, Boutrel B, de Lecea L (2005) Stress and arousal. Mol Neurobiol 32(3):285–294CrossRefPubMedGoogle Scholar
  85. 85.
    Hetz C, Chevet E, Harding HP (2013) Targeting the unfolded protein response in disease. Nat Rev Drug Discov 12(9):703–719CrossRefPubMedGoogle Scholar
  86. 86.
    Blair PS, Byard RW, Fleming PJ (2012) Sudden unexpected death in infancy (SUDI): suggested classification and applications to facilitate research activity. Forensic Sci Med Pathol 8(3):312–315CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Nicholas J. Hunt
    • 1
    • 2
  • Karen A. Waters
    • 1
    • 2
    • 3
  • Rita Machaalani
    • 1
    • 2
    • 3
    Email author
  1. 1.SIDS and Sleep Apnoea Laboratory, Department of Medicine, Sydney Medical SchoolUniversity of SydneySydneyAustralia
  2. 2.BOSCH Institute of Biomedical ResearchUniversity of SydneySydneyAustralia
  3. 3.The Children’s HospitalWestmeadAustralia

Personalised recommendations